MedTrace Logo

Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer

NCT05922553 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2025-08-06

No results posted yet for this study

Summary

This study aims to use a two arms randomized clinical trial study to evaluate the effectiveness of the effective constituent of Mukbang in helping children with cancer hospitalized for radiotherapy and chemotherapy to improve their appetite, nutritional status and quality of life.

Conditions

  • Children With Cancer

Interventions

BEHAVIORAL

Active Ingredient Mukbang

Mukbang videos include the items which can truly improve the appetite of children with cancer, such as food images, eating sound and interactivity.

BEHAVIORAL

General short videos

Short videos that don't contain any food cues.

Sponsors & Collaborators

  • Wei XIA, PhD

    lead OTHER

Principal Investigators

  • Wei Xia, PhD · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2026-03-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05922553 on ClinicalTrials.gov